These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8400205

  • 1. Counselling of workers handling vaccinia virus.
    Williams NR, Cooper BM.
    Occup Med (Lond); 1993 Aug; 43(3):125-7. PubMed ID: 8400205
    [Abstract] [Full Text] [Related]

  • 2. Risks associated with vaccinia virus in the laboratory.
    MacNeil A, Reynolds MG, Damon IK.
    Virology; 2009 Mar 01; 385(1):1-4. PubMed ID: 19118854
    [Abstract] [Full Text] [Related]

  • 3. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ, Advisory Committee on Immunization Practices, Healthcare Infection Control Practices Advisory Committee.
    MMWR Recomm Rep; 2003 Apr 04; 52(RR-7):1-16. PubMed ID: 12710832
    [Abstract] [Full Text] [Related]

  • 4. Pros and cons of vaccinia immunization.
    J Occup Med; 1992 Aug 04; 34(8):757. PubMed ID: 1324299
    [No Abstract] [Full Text] [Related]

  • 5. Smallpox vaccination for investigators.
    Danner K.
    Lancet; 1989 Dec 02; 2(8675):1337-8. PubMed ID: 2574286
    [No Abstract] [Full Text] [Related]

  • 6. Frequency of vaccinia virus isolation on semipermeable versus nonocclusive dressings covering smallpox vaccination sites in hospital personnel.
    Hepburn MJ, Dooley DP, Murray CK, Hospenthal DR, Hill BL, Nauschuetz WN, Davis KA, Crouch HK, McAllister CK.
    Am J Infect Control; 2004 May 02; 32(3):126-30. PubMed ID: 15153922
    [Abstract] [Full Text] [Related]

  • 7. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J, Casey CG, Bell DM, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2003 Feb 21; 52(RR-4):1-28. PubMed ID: 12617510
    [Abstract] [Full Text] [Related]

  • 8. [Analysis on status and characteristics of laboratory-acquired vaccinia virus infections cases].
    Wei Q, Lu XC, Wu GZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb 21; 27(1):73-5. PubMed ID: 23855138
    [Abstract] [Full Text] [Related]

  • 9. Laboratory-acquired vaccinia infection.
    Loeb M, Zando I, Orvidas MC, Bialachowski A, Groves D, Mahoney J.
    Can Commun Dis Rep; 2003 Aug 01; 29(15):134-6. PubMed ID: 12916394
    [No Abstract] [Full Text] [Related]

  • 10. Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015.
    Petersen BW, Harms TJ, Reynolds MG, Harrison LH.
    MMWR Morb Mortal Wkly Rep; 2016 Mar 18; 65(10):257-62. PubMed ID: 26985679
    [Abstract] [Full Text] [Related]

  • 11. Absence of oropharyngeal vaccinia virus after vaccinia (smallpox) vaccination.
    Klote MM, Ludwig GV, Ulrich MP, Black LA, Hack DC, Engler RJ, Martin BL.
    Ann Allergy Asthma Immunol; 2005 Jun 18; 94(6):682-5. PubMed ID: 15984602
    [Abstract] [Full Text] [Related]

  • 12. Transmission of vaccinia virus and rationale for measures for prevention.
    Lane JM, Fulginiti VA.
    Clin Infect Dis; 2003 Jul 15; 37(2):281-4. PubMed ID: 12856220
    [Abstract] [Full Text] [Related]

  • 13. Immune control strategies for vaccinia virus-related laboratory-acquired infections.
    Wei Q, Jiang MN, Han J, Wang ZJ.
    Biomed Environ Sci; 2014 Feb 15; 27(2):142-6. PubMed ID: 24625408
    [Abstract] [Full Text] [Related]

  • 14. Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct.
    Mempel M, Isa G, Klugbauer N, Meyer H, Wildi G, Ring J, Hofmann F, Hofmann H.
    J Invest Dermatol; 2003 Mar 15; 120(3):356-8. PubMed ID: 12603846
    [Abstract] [Full Text] [Related]

  • 15. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR, Garman PM, Kim SH, Schmader TJ, Nieding WJ, Pike JG, Knight R, Johnston SC, Huggins JW, Kortepeter MG, Korman L, Ranadive M, Quinn X, Meyers MS.
    Vaccine; 2015 Jun 12; 33(26):2990-6. PubMed ID: 25930115
    [Abstract] [Full Text] [Related]

  • 16. Laboratory-acquired vaccinia exposures and infections--United States, 2005-2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Apr 18; 57(15):401-4. PubMed ID: 18418346
    [Abstract] [Full Text] [Related]

  • 17. Laboratory-acquired vaccinia virus infection--Virginia, 2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Jul 31; 58(29):797-800. PubMed ID: 19644439
    [Abstract] [Full Text] [Related]

  • 18. Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections.
    Isaacs SN.
    Methods Mol Biol; 2012 Jul 31; 890():1-22. PubMed ID: 22688758
    [Abstract] [Full Text] [Related]

  • 19. Absence of pharyngeal shedding of vaccinia following smallpox vaccination.
    Talbot TR, Peters J, Wright PF, Edwards KM.
    Am J Infect Control; 2007 Sep 31; 35(7):486-8. PubMed ID: 17765564
    [Abstract] [Full Text] [Related]

  • 20. Working Safely with Vaccinia Virus: Laboratory Technique and Review of Published Cases of Accidental Laboratory Infections with Poxviruses.
    Isaacs SN.
    Methods Mol Biol; 2019 Sep 31; 2023():1-27. PubMed ID: 31240668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.